Cargando…
Editorial: Innate immunity and severe asthma: From microbiome to target therapy
Autores principales: | Bagnasco, Diego, Caminati, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834275/ https://www.ncbi.nlm.nih.gov/pubmed/36643921 http://dx.doi.org/10.3389/fimmu.2022.1114275 |
Ejemplares similares
-
Type 2 immunity in asthma
por: Caminati, Marco, et al.
Publicado: (2018) -
Editorial: Innate immune cell therapy of cancer
por: Khatwani, Natasha, et al.
Publicado: (2022) -
New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
por: Caminati, Marco, et al.
Publicado: (2019) -
Editorial: Targeted Antigen Delivery: Bridging Innate and Adaptive Immunity
por: Manoury, Bénédicte, et al.
Publicado: (2019) -
Editorial: STATs and IRFs in Innate Immunity: From Transcriptional Regulators to Therapeutic Targets
por: Lee, Chien-Kuo, et al.
Publicado: (2019)